MODIFICATION TO RAPID DRUG SCREEN 9-PANEL

Enzyme Immunoassay, Amphetamine

AMERICAN BIO MEDICA CORP.

The following data is part of a premarket notification filed by American Bio Medica Corp. with the FDA for Modification To Rapid Drug Screen 9-panel.

Pre-market Notification Details

Device IDK002447
510k NumberK002447
Device Name:MODIFICATION TO RAPID DRUG SCREEN 9-PANEL
ClassificationEnzyme Immunoassay, Amphetamine
Applicant AMERICAN BIO MEDICA CORP. 1001 G STREET, NW SUITE 500W Washington,  DC  20001
ContactJohn B Dubeck
CorrespondentJohn B Dubeck
AMERICAN BIO MEDICA CORP. 1001 G STREET, NW SUITE 500W Washington,  DC  20001
Product CodeDKZ  
Subsequent Product CodeDIO
Subsequent Product CodeDIS
Subsequent Product CodeDJC
Subsequent Product CodeDJG
Subsequent Product CodeJXM
Subsequent Product CodeLCM
Subsequent Product CodeLDJ
Subsequent Product CodeLFI
CFR Regulation Number862.3100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-08-09
Decision Date2000-11-16

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
10694644350781 K002447 000
10694644350798 K002447 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.